Clinical Trial Update: A Double Blind Placebo Controlled Study to Assess the Efficacy on Joint Damage in RA Patients [Phase 4]

View source ↗

Summary

A phase 4 double-blind, placebo-controlled trial in rheumatoid arthritis evaluated the treatment's ability to prevent joint damage; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Rheumatoid Arthritis | Phase 4 | Status: COMPLETED